Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Osteoporosis, Postmenopausal 1Leiomyoma 1Endometriosis 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1986Cisplatin 1855Carboplatin 1559Gemcitabine 1454Paclitaxel 1320Bevacizumab 1318pembrolizumab 1236Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 978Magnetic Resonance Spectroscopy 969Nivolumab 936Rituximab 929Drug Therapy 914Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 815Blood Specimen Collection 815Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × tibolone × Clear all
NCT05568940 2024-05-30

eTAPE

McGill University Health Centre/Research Institute of the McGill University Health Centre

Withdrawn

Endometriosis, Leiomyoma

NCT00165204 2007-12-21

Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy

Dana-Farber Cancer Institute

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms, Osteoporosis, Postmenopausal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡